How eBand Technology Personalizes Nicotine Replacement Therapy

Nicotine replacement therapy (NRT) has been widely used for decades to help people quit smoking. Patches, gums, lozenges, and inhalers deliver controlled amounts of nicotine to reduce withdrawal symptoms. While these methods offer some relief, they share one major limitation: they cannot adapt to the individual user’s unique physiological responses. Every smoker experiences cravings differently, yet traditional NRT products deliver a uniform dose at fixed intervals, regardless of the body’s real-time needs.

The eBand wearable device introduces a smarter, personalized approach. By measuring physiological signals and releasing nicotine only when withdrawal is detected, it transforms NRT into a tailored therapy that responds to each user’s journey. This personalization not only improves success rates but also makes the process of quitting healthier and less stressful.

Understanding the Need for Personalized Nicotine Delivery

Quitting smoking is not the same for everyone. Factors such as how long a person has smoked, their level of dependence, and their stress response all influence cravings. Some people may need higher doses of nicotine at certain times, while others require minimal support. Fixed-dose therapies often fail because they do not match these variations.

For example, a smoker may experience stronger withdrawal symptoms in the morning, but a patch delivers the same steady dose throughout the day. Others may feel cravings during stressful situations, but gum or lozenges depend on the individual to self-administer at the right time. This mismatch creates gaps in support and increases the risk of relapse.

Personalization in nicotine therapy means delivering the right amount of medication at the right time—something conventional methods cannot achieve consistently. eBand was designed specifically to bridge this gap.

How eBand Measures Withdrawal in Real Time

The foundation of eBand’s personalized therapy is its biometric monitoring system. The device continuously tracks two indicators strongly linked to nicotine withdrawal: blood pressure variability and skin conductance.

– Blood pressure variability is measured using a photonic integrated circuit and laser Doppler vibrometers, which can accurately detect changes without invasive methods.

– Skin conductance reflects stress levels by measuring electrical current changes through the skin, caused by sweat gland activity during cravings.

When both parameters show significant deviation from baseline, eBand interprets this as a withdrawal event. The device then prepares to release a carefully measured dose of nicotine—or bupropion—tailored to the intensity of the symptoms.

This real-time detection ensures that medication is not released unnecessarily. Instead, it is provided only when the body truly needs it, creating a responsive therapy that evolves with the user’s condition.

Precise Medication Release Through Nano-Tube Technology

The delivery system is another area where eBand stands apart. Instead of relying on patches or oral intake, it uses densely packed multiwalled carbon nano-tubes (MWCT) to administer medication through the skin.

When a voltage threshold is reached, these nano-tubes shift from repelling liquid to releasing it, allowing a small droplet of nicotine solution to pass through onto the skin for gradual absorption. This process is highly controlled, ensuring that only the necessary amount of medication is delivered at a time.

Over the course of therapy, eBand reduces the amount released as withdrawal symptoms decrease. This gradual tapering supports the body’s natural recovery from nicotine dependence, minimizing the risk of forming a new reliance on replacement products.

Personalized Quitting Journeys with eBand

The result of this technology is a quitting process that feels tailored rather than generic. Users benefit from adaptive dosing, continuous monitoring, and clear feedback through the connected smartphone app. Progress can be tracked over time, reinforcing motivation and helping users see measurable improvements.

Personalization also makes quitting less stressful. Instead of second-guessing when to take the next piece of gum or worrying about whether a patch will be enough, users can trust that eBand is handling the process in the background. This reassurance makes it easier to focus on building new habits and moving toward a smoke-free life.

With its ability to respond to individual needs in real time, eBand represents a new standard in nicotine replacement therapy. It combines advanced science with user-friendly design to create a tool that not only supports quitting but adapts to the unique journey of each smoker.